Figure 4
Figure 4. PPXbd inhibits fibrin and thrombin generation on collagen/low [TF]wall at arterial shear rate. (A-B) Anticoagulated whole blood (CTI, 4 μg/mL) was treated with PPXbd (250 μg/mL) and was perfused over collagen or collagen/low [TF]wall surface at 1000 s−1 under constant pressure drop conditions (constant ΔP). Platelet deposition on collagen was unaffected by PPXbd. Fibrin generation was inhibited by PPXbd on (D) collagen/low [TF]wall surface but not on (C) the collagen-alone surface. (E-F) Consistent with the reduction in fibrin on collagen/low [TF]wall, thrombin generation at low [TF]wall was also lowered by PPXbd after 300 seconds. *P < .05.

PPXbd inhibits fibrin and thrombin generation on collagen/low [TF]wall at arterial shear rate. (A-B) Anticoagulated whole blood (CTI, 4 μg/mL) was treated with PPXbd (250 μg/mL) and was perfused over collagen or collagen/low [TF]wall surface at 1000 s−1 under constant pressure drop conditions (constant ΔP). Platelet deposition on collagen was unaffected by PPXbd. Fibrin generation was inhibited by PPXbd on (D) collagen/low [TF]wall surface but not on (C) the collagen-alone surface. (E-F) Consistent with the reduction in fibrin on collagen/low [TF]wall, thrombin generation at low [TF]wall was also lowered by PPXbd after 300 seconds. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal